Of note, a significant proportion of anti-PM-Scl-/anti-Scl-70-positive patients develop pulmonary fibrosis, raising the question of long-term effects of severe COVID-19 in these patients (28). The gene discussed is KRT7; the disease is pulmonary fibrosis.